免疫組織化学（IHC）の市場規模、シェア、予測、動向分析：オファリング別（試薬[固定、緩衝液、ブロッキング、抗体]）、キット別、装置別[染色、イメージング]、メソッドプロセス別、用途別、エンドユーザー別 - 2031年までの世界予測

世界の免疫組織化学市場は、2024年から2031年までのCAGRが7.2%で、2031年までに40億8,000万米ドルに達すると予測されています。

本レポートは、広範な2次調査と1次調査、市場シナリオの詳細な分析を経て、主要な市場促進要因、抑制要因、課題、機会の分析から構成されています。免疫組織化学の世界市場の成長は、高齢者の慢性疾患の有病率の増加、希少疾患への関心の高まり、早期疾患診断の重要性に対する意識の高まり、研究開発費の増加、創薬開発需要の高まり、感染症負担の増加、研究活動への資金提供の増加、ヘルスケア支出の増加によって牽引されています。しかし、標準化されたプロトコルの欠如がこの市場の成長を抑制しています。

さらに、個別化医療への傾斜、ゲノミクスとプロテオミクスの革新、組織化学における自動化の進展は、市場成長の機会を生み出すと期待されています。しかしながら、代替技術の利用可能性が世界の免疫組織化学市場における大きな課題です。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場成長の要因

• 概要
• 促進要因
  • 高齢者人口の増加に伴う慢性疾患の有病率の上昇
  • 希少疾患への注目の高まり
  • 疾患の早期診断に関する意識の高まり
  • 研究開発費の増加
  • 創薬開発の需要増加
  • 感染症の流行増加
  • 研究活動への資金提供の増加
  • ヘルスケア支出の増加
• 抑制要因
  • 標準化されたプロトコルの欠如
• 機会
  • 個別化医療への志向の高まり
  • ゲノミクスとプロテオミクスの進歩
  • 免疫組織化学の自動化の増加
• 課題
  • 代替技術の利用可能性
• 動向
  • AIベースの組織化学
  • Multiplex IHCの使用
• 因子分析
• ケーススタディ
• 価格分析
• 規制分析
  • 米国
  • カナダ
  • 欧州
  • 中国
  • 日本
  • インド
  • ラテンアメリカ
  • 中東
• 価格分析
• ポーターのファイブフォース分析

第5章 免疫組織化学の市場評価：オファリング別

• 概要
• 消耗品
  • 試薬
    • 固定試薬
    • 抗原回収試薬
    • 緩衝液
    • ブロッキング試薬
    • 抗体
    • コントロール試薬
    • 発色基質
    • カウンターステイン
  • その他アクセサリー
• 装置
  • 染色システム
  • イメージングシステム
  • スライドスキャナー
  • 組織マイクロアレイ
• サービス・ソフトウェア

第6章 免疫組織化学の市場評価：メソッド別

• 概要
• アビジン-ビオチン複合体
• ポリマーベースの免疫組織化学
• 触媒シグナル増幅法（CSA）
• 蛍光チラミド増幅法
• 改良型触媒シグナル増幅法（iCSA）
• 多染色免疫組織化学
• 標識ストレプトアビジンビオチン（LSAB）
• PAP法

第7章 免疫組織化学の市場評価：プロセス別

• 概要
• サンプル調製
• 抗原回収
• バックグラウンドブロック
• 標的検出
• サンプルの可視化

第8章 免疫組織化学の市場評価：用途別

• 概要
• 研究・その他の用途
  • 創薬
  • 農業・動物研究
  • その他の用途
• 臨床応用
  • 生殖医療
  • 腫瘍学
  • 感染症
  • その他の臨床応用

第9章 免疫組織化学の市場評価：エンドユーザー別

• 概要
• 製薬・バイオテクノロジー企業
• 病院・診断研究所
• 学術機関・研究センター
• 受託研究機関
• その他のエンドユーザー

第10章 免疫組織化学の市場評価：地域別

• 概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • その他欧州
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • その他アジア太平洋
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
• 中東・アフリカ

第11章 競合分析

• 概要
• 主要成長戦略
• 競合ベンチマーキング
• 競合ダッシュボード
  • 業界リーダー
  • 市場差別化要因
  • 先行企業
  • 新興企業
• 主要企業の市場シェア分析 / 市場ランキング（2023年）

第12章 企業プロファイル（事業概要、財務概要、製品ポートフォリオ、戦略的展開、SWOT分析*）

• F. Hoffmann-La Roche Ltd（Switzerland）
• Danaher Corporation（U.S.）
• Agilent Technologies, Inc.（U.S.）
• Merck KGaA（Germany）
• Bio-Rad Laboratories, Inc.（U.S.）
• Eagle Biosciences, Inc.（U.S.）
• Thermo Fisher Scientific Inc.（U.S）
• Cell Signaling Technology, Inc.（U.S.）
• PerkinElmer, Inc.（U.S.）
• Bio SB Inc.（U.S.）
• Biocare Medical, LLC.（U.S.）
• Bio-Genex Laboratories（U.S.）
• CANDOR Bioscience GmbH（Germany）
• Innovex Biosciences Inc.（U.S.）

（注：上位5社のSWOT分析を提供します）

第13章 付録

LIST OF TABLES

• Table 1 Global Immunohistochemistry Market, by Offering, 2022-2031 (USD Million)
• Table 2 Global Immunohistochemistry Consumables Market, by Type, 2022-2031 (USD Million)
• Table 3 Global Immunohistochemistry Consumables Market, by Country/Region, 2022-2031 (USD Million)
• Table 4 Global Immunohistochemistry Reagents Market, by Type, 2022-2031 (USD Million)
• Table 5 Global Immunohistochemistry Reagents Market, by Country/Region, 2022-2031 (USD Million)
• Table 6 Global Immunohistochemistry Fixation Reagents Market, by Country/Region, 2022-2031 (USD Million)
• Table 7 Global Immunohistochemistry Antigen Retrieval Market, by Country/Region, 2022-2031 (USD Million)
• Table 8 Global Immunohistochemistry Buffers Market, by Country/Region, 2022-2031 (USD Million)
• Table 9 Global Immunohistochemistry Blocking Reagents Market, by Country/Region, 2022-2031 (USD Million)
• Table 10 Global Immunohistochemistry Antibodies Market, by Country/Region, 2022-2031 (USD Million)
• Table 11 Global Immunohistochemistry Control Reagents Market, by Country/Region, 2022-2031 (USD Million)
• Table 12 Global Immunohistochemistry Chromogenic Substrates Market, by Country/Region, 2022-2031 (USD Million)
• Table 13 Global Immunohistochemistry Counterstains Market, by Country/Region, 2022-2031 (USD Million)
• Table 14 Global Immunohistochemistry Counterstains Market, by Country/Region, 2022-2031 (USD Million)
• Table 15 Global Other Immunohistochemistry Accessories Market, by Country/Region, 2022-2031 (USD Million)
• Table 16 Global Immunohistochemistry Equipment Market, by Type, 2022-2031 (USD Million)
• Table 17 Global Immunohistochemistry Equipment Market, by Country/Region, 2022-2031 (USD Million)
• Table 18 Global Immunohistochemistry Staining Systems Market, by Country/Region, 2022-2031 (USD Million)
• Table 19 Global Immunohistochemistry Imaging Systems Market, by Country/Region, 2022-2031 (USD Million)
• Table 20 Global Immunohistochemistry Slide Scanners Market, by Country/Region, 2022-2031 (USD Million)
• Table 21 Global Immunohistochemistry Tissue Microarrays Market, by Country/Region, 2022-2031 (USD Million)
• Table 22 Global Immunohistochemistry Services & Software Market, by Country/Region, 2022-2031 (USD Million)
• Table 23 Global Immunohistochemistry Market, by Method, 2022-2031 (USD Million)
• Table 24 Global Avidin-Biotin Complex Market, by Country/Region, 2022-2031 (USD Million)
• Table 25 Global Polymer-Based Immunohistochemistry Market, by Country/Region, 2022-2031 (USD Million)
• Table 26 Global Catalysed Signal Amplification (CSA) Market, by Country/Region, 2022-2031 (USD Million)
• Table 27 Global Fluorescyl-tyramide Amplification Market, by Country/Region, 2022-2031 (USD Million)
• Table 28 Global Improved Catalyzed Signal Amplification (iCSA) Market, by Country/Region, 2022-2031 (USD Million)
• Table 29 Global Multi-Staining Immunohistochemistry Market, by Country/Region, 2022-2031 (USD Million)
• Table 30 Global Labeled Streptavidin Biotin (LSAB) Market, by Country/Region, 2022-2031 (USD Million)
• Table 31 Global PAP Method Market, by Country/Region, 2022-2031 (USD Million)
• Table 32 Global Immunohistochemistry Market, by Process, 2022-2031 (USD Million)
• Table 33 Global Immunohistochemistry Sample Preparation Market, by Country/Region, 2022-2031 (USD Million)
• Table 34 Global Immunohistochemistry Antigen Retrieval Market, by Country/Region, 2022-2031 (USD Million)
• Table 35 Global Immunohistochemistry Background Blocking Market, by Country/Region, 2022-2031 (USD Million)
• Table 36 Global Immunohistochemistry Target Detection Market, by Country/Region, 2022-2031 (USD Million)
• Table 37 Global Immunohistochemistry Sample Visualization Market, by Country/Region, 2022-2031 (USD Million)
• Table 38 Global Immunohistochemistry Market, by Application, 2022-2031 (USD Million)
• Table 39 Global Immunohistochemistry Market for Research and Other Applications, by Type, 2022-2031 (USD Million)
• Table 40 Global Immunohistochemistry Market for Research and Other Applications, by Country/Region, 2022-2031 (USD Million)
• Table 41 Global Immunohistochemistry Market for Drug Discovery, by Country/Region, 2022-2031 (USD Million)
• Table 42 Global Immunohistochemistry Market for Agriculture & Animal Research, by Country/Region, 2022-2031 (USD Million)
• Table 43 Global Immunohistochemistry Market for Other Applications, by Country/Region, 2022-2031 (USD Million)
• Table 44 Global Immunohistochemistry Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 45 Global Immunohistochemistry Market for Clinical Applications, by Country/Region, 2022-2031 (USD Million)
• Table 46 Global Immunohistochemistry Market for Reproductive Health, by Country/Region, 2022-2031 (USD Million)
• Table 47 Global Immunohistochemistry Market for Oncology, by Country/Region, 2022-2031 (USD Million)
• Table 48 Global Immunohistochemistry Market for Infectious Disease, by Country/Region, 2022-2031 (USD Million)
• Table 49 Global Immunohistochemistry Market for Other Clinical Applications, by Country/Region, 2022-2031 (USD Million)
• Table 50 Global Immunohistochemistry Market, by End User, 2022-2031 (USD Million)
• Table 51 Global Immunohistochemistry Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2022-2031 (USD Million)
• Table 52 Global Immunohistochemistry Market for Hospitals & Diagnostic Laboratories, by Country/Region, 2022-2031 (USD Million)
• Table 53 Global Immunohistochemistry Market for Academic Institutes & Research Centers, by Country/Region, 2022-2031 (USD Million)
• Table 54 Global Immunohistochemistry Market for Contract Research Organizations, by Country/Region, 2022-2031 (USD Million)
• Table 55 Global Immunohistochemistry Market for Other End Users, by Country/Region, 2022-2031 (USD Million)
• Table 56 Global Immunohistochemistry Market, by Country/Region, 2022-2031 (USD Million)
• Table 57 North America: Immunohistochemistry Market, by Country, 2022-2031 (USD Million)
• Table 58 North America: Immunohistochemistry Market, by Offering, 2022-2031 (USD Million)
• Table 59 North America: Immunohistochemistry Consumables Market, by Type, 2022-2031 (USD Million)
• Table 60 North America: Immunohistochemistry Reagents Market, by Type, 2022-2031 (USD Million)
• Table 61 North America: Immunohistochemistry Equipment Market, by Type, 2022-2031 (USD Million)
• Table 62 North America: Immunohistochemistry Market, by Method, 2022-2031 (USD Million)
• Table 63 North America: Immunohistochemistry Market, by Process, 2022-2031 (USD Million)
• Table 64 North America: Immunohistochemistry Market, by Application, 2022-2031 (USD Million)
• Table 65 North America: Immunohistochemistry Market for Research and Other Applications, by Type, 2022-2031 (USD Million)
• Table 66 North America: Immunohistochemistry Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 67 North America: Immunohistochemistry Market, by End User, 2022-2031 (USD Million)
• Table 68 U.S.: Immunohistochemistry Market, by Offering, 2022-2031 (USD Million)
• Table 69 U.S.: Immunohistochemistry Consumables Market, by Type, 2022-2031 (USD Million)
• Table 70 U.S.: Immunohistochemistry Reagents Market, by Type, 2022-2031 (USD Million)
• Table 71 U.S.: Immunohistochemistry Equipment Market, by Type, 2022-2031 (USD Million)
• Table 72 U.S.: Immunohistochemistry Market, by Method, 2022-2031 (USD Million)
• Table 73 U.S.: Immunohistochemistry Market, by Process, 2022-2031 (USD Million)
• Table 74 U.S.: Immunohistochemistry Market, by Application, 2022-2031 (USD Million)
• Table 75 U.S.: Immunohistochemistry Market for Research and Other Applications, by Type, 2022-2031 (USD Million)
• Table 76 U.S.: Immunohistochemistry Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 77 U.S.: Immunohistochemistry Market, by End User, 2022-2031 (USD Million)
• Table 78 Canada: Immunohistochemistry Market, by Offering, 2022-2031 (USD Million)
• Table 79 Canada: Immunohistochemistry Consumables Market, by Type, 2022-2031 (USD Million)
• Table 80 Canada: Immunohistochemistry Reagents Market, by Type, 2022-2031 (USD Million)
• Table 81 Canada: Immunohistochemistry Equipment Market, by Type, 2022-2031 (USD Million)
• Table 82 Canada: Immunohistochemistry Market, by Method, 2022-2031 (USD Million)
• Table 83 Canada: Immunohistochemistry Market, by Process, 2022-2031 (USD Million)
• Table 84 Canada: Immunohistochemistry Market, by Application, 2022-2031 (USD Million)
• Table 85 Canada: Immunohistochemistry Market for Research and Other Applications, by Type, 2022-2031 (USD Million)
• Table 86 Canada: Immunohistochemistry Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 87 Canada: Immunohistochemistry Market, by End User, 2022-2031 (USD Million)
• Table 88 Europe: Immunohistochemistry Market, by Country/Region, 2022-2031 (USD Million)
• Table 89 Europe: Immunohistochemistry Market, by Offering, 2022-2031 (USD Million)
• Table 90 Europe: Immunohistochemistry Consumables Market, by Type, 2022-2031 (USD Million)
• Table 91 Europe: Immunohistochemistry Reagents Market, by Type, 2022-2031 (USD Million)
• Table 92 Europe: Immunohistochemistry Equipment Market, by Type, 2022-2031 (USD Million)
• Table 93 Europe: Immunohistochemistry Market, by Method, 2022-2031 (USD Million)
• Table 94 Europe: Immunohistochemistry Market, by Process, 2022-2031 (USD Million)
• Table 95 Europe: Immunohistochemistry Market, by Application, 2022-2031 (USD Million)
• Table 96 Europe: Immunohistochemistry Market for Research and Other Applications, by Type, 2022-2031 (USD Million)
• Table 97 Europe: Immunohistochemistry Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 98 Europe: Immunohistochemistry Market, by End User, 2022-2031 (USD Million)
• Table 99 Germany: Immunohistochemistry Market, by Offering, 2022-2031 (USD Million)
• Table 100 Germany: Immunohistochemistry Consumables Market, by Type, 2022-2031 (USD Million)
• Table 101 Germany: Immunohistochemistry Reagents Market, by Type, 2022-2031 (USD Million)
• Table 102 Germany: Immunohistochemistry Equipment Market, by Type, 2022-2031 (USD Million)
• Table 103 Germany: Immunohistochemistry Market, by Method, 2022-2031 (USD Million)
• Table 104 Germany: Immunohistochemistry Market, by Process, 2022-2031 (USD Million)
• Table 105 Germany: Immunohistochemistry Market, by Application, 2022-2031 (USD Million)
• Table 106 Germany: Immunohistochemistry Market for Research and Other Applications, by Type, 2022-2031 (USD Million)
• Table 107 Germany: Immunohistochemistry Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 108 Germany: Immunohistochemistry Market, by End User, 2022-2031 (USD Million)
• Table 109 France: Immunohistochemistry Market, by Offering, 2022-2031 (USD Million)
• Table 110 France: Immunohistochemistry Consumables Market, by Type, 2022-2031 (USD Million)
• Table 111 France: Immunohistochemistry Reagents Market, by Type, 2022-2031 (USD Million)
• Table 112 France: Immunohistochemistry Equipment Market, by Type, 2022-2031 (USD Million)
• Table 113 France: Immunohistochemistry Market, by Method, 2022-2031 (USD Million)
• Table 114 France: Immunohistochemistry Market, by Process, 2022-2031 (USD Million)
• Table 115 France: Immunohistochemistry Market, by Application, 2022-2031 (USD Million)
• Table 116 France: Immunohistochemistry Market for Research and Other Applications, by Type, 2022-2031 (USD Million)
• Table 117 France: Immunohistochemistry Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 118 France: Immunohistochemistry Market, by End User, 2022-2031 (USD Million)
• Table 119 U.K.: Immunohistochemistry Market, by Offering, 2022-2031 (USD Million)
• Table 120 U.K.: Immunohistochemistry Consumables Market, by Type, 2022-2031 (USD Million)
• Table 121 U.K.: Immunohistochemistry Reagents Market, by Type, 2022-2031 (USD Million)
• Table 122 U.K.: Immunohistochemistry Equipment Market, by Type, 2022-2031 (USD Million)
• Table 123 U.K.: Immunohistochemistry Market, by Method, 2022-2031 (USD Million)
• Table 124 U.K.: Immunohistochemistry Market, by Process, 2022-2031 (USD Million)
• Table 125 U.K.: Immunohistochemistry Market, by Application, 2022-2031 (USD Million)
• Table 126 U.K.: Immunohistochemistry Market for Research and Other Applications, by Type, 2022-2031 (USD Million)
• Table 127 U.K.: Immunohistochemistry Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 128 U.K.: Immunohistochemistry Market, by End User, 2022-2031 (USD Million)
• Table 129 Italy: Immunohistochemistry Market, by Offering, 2022-2031 (USD Million)
• Table 130 Italy: Immunohistochemistry Consumables Market, by Type, 2022-2031 (USD Million)
• Table 131 Italy: Immunohistochemistry Reagents Market, by Type, 2022-2031 (USD Million)
• Table 132 Italy: Immunohistochemistry Equipment Market, by Type, 2022-2031 (USD Million)
• Table 133 Italy: Immunohistochemistry Market, by Method, 2022-2031 (USD Million)
• Table 134 Italy: Immunohistochemistry Market, by Process, 2022-2031 (USD Million)
• Table 135 Italy: Immunohistochemistry Market, by Application, 2022-2031 (USD Million)
• Table 136 Italy: Immunohistochemistry Market for Research and Other Applications, by Type, 2022-2031 (USD Million)
• Table 137 Italy: Immunohistochemistry Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 138 Italy: Immunohistochemistry Market, by End User, 2022-2031 (USD Million)
• Table 139 Spain: Immunohistochemistry Market, by Offering, 2022-2031 (USD Million)
• Table 140 Spain: Immunohistochemistry Consumables Market, by Type, 2022-2031 (USD Million)
• Table 141 Spain: Immunohistochemistry Reagents Market, by Type, 2022-2031 (USD Million)
• Table 142 Spain: Immunohistochemistry Equipment Market, by Type, 2022-2031 (USD Million)
• Table 143 Spain: Immunohistochemistry Market, by Method, 2022-2031 (USD Million)
• Table 144 Spain: Immunohistochemistry Market, by Process, 2022-2031 (USD Million)
• Table 145 Spain: Immunohistochemistry Market, by Application, 2022-2031 (USD Million)
• Table 146 Spain: Immunohistochemistry Market for Research and Other Applications, by Type, 2022-2031 (USD Million)
• Table 147 Spain: Immunohistochemistry Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 148 Spain: Immunohistochemistry Market, by End User, 2022-2031 (USD Million)
• Table 149 Rest of Europe: Immunohistochemistry Market, by Offering, 2022-2031 (USD Million)
• Table 150 Rest of Europe: Immunohistochemistry Consumables Market, by Type, 2022-2031 (USD Million)
• Table 151 Rest of Europe: Immunohistochemistry Reagents Market, by Type, 2022-2031 (USD Million)
• Table 152 Rest of Europe: Immunohistochemistry Equipment Market, by Type, 2022-2031 (USD Million)
• Table 153 Rest of Europe: Immunohistochemistry Market, by Method, 2022-2031 (USD Million)
• Table 154 Rest of Europe: Immunohistochemistry Market, by Process, 2022-2031 (USD Million)
• Table 155 Rest of Europe: Immunohistochemistry Market, by Application, 2022-2031 (USD Million)
• Table 156 Rest of Europe: Immunohistochemistry Market for Research and Other Applications, by Type, 2022-2031 (USD Million)
• Table 157 Rest of Europe: Immunohistochemistry Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 158 Rest of Europe: Immunohistochemistry Market, by End User, 2022-2031 (USD Million)
• Table 159 Asia-Pacific: Immunohistochemistry Market, by Country/Region, 2022-2031 (USD Million)
• Table 160 Asia-Pacific: Immunohistochemistry Market, by Offering, 2022-2031 (USD Million)
• Table 161 Asia-Pacific: Immunohistochemistry Consumables Market, by Type, 2022-2031 (USD Million)
• Table 162 Asia-Pacific: Immunohistochemistry Reagents Market, by Type, 2022-2031 (USD Million)
• Table 163 Asia-Pacific: Immunohistochemistry Equipment Market, by Type, 2022-2031 (USD Million)
• Table 164 Asia-Pacific: Immunohistochemistry Market, by Method, 2022-2031 (USD Million)
• Table 165 Asia-Pacific: Immunohistochemistry Market, by Process, 2022-2031 (USD Million)
• Table 166 Asia-Pacific: Immunohistochemistry Market, by Application, 2022-2031 (USD Million)
• Table 167 Asia-Pacific: Immunohistochemistry Market for Research and Other Applications, by Type, 2022-2031 (USD Million)
• Table 168 Asia-Pacific: Immunohistochemistry Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 169 Asia-Pacific: Immunohistochemistry Market, by End User, 2022-2031 (USD Million)
• Table 170 Japan: Immunohistochemistry Market, by Offering, 2022-2031 (USD Million)
• Table 171 Japan: Immunohistochemistry Consumables Market, by Type, 2022-2031 (USD Million)
• Table 172 Japan: Immunohistochemistry Reagents Market, by Type, 2022-2031 (USD Million)
• Table 173 Japan: Immunohistochemistry Equipment Market, by Type, 2022-2031 (USD Million)
• Table 174 Japan: Immunohistochemistry Market, by Method, 2022-2031 (USD Million)
• Table 175 Japan: Immunohistochemistry Market, by Process, 2022-2031 (USD Million)
• Table 176 Japan: Immunohistochemistry Market, by Application, 2022-2031 (USD Million)
• Table 177 Japan: Immunohistochemistry Market for Research and Other Applications, by Type, 2022-2031 (USD Million)
• Table 178 Japan: Immunohistochemistry Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 179 Japan: Immunohistochemistry Market, by End User, 2022-2031 (USD Million)
• Table 180 China: Immunohistochemistry Market, by Offering, 2022-2031 (USD Million)
• Table 181 China: Immunohistochemistry Consumables Market, by Type, 2022-2031 (USD Million)
• Table 182 China: Immunohistochemistry Reagents Market, by Type, 2022-2031 (USD Million)
• Table 183 China: Immunohistochemistry Equipment Market, by Type, 2022-2031 (USD Million)
• Table 184 China: Immunohistochemistry Market, by Method, 2022-2031 (USD Million)
• Table 185 China: Immunohistochemistry Market, by Process, 2022-2031 (USD Million)
• Table 186 China: Immunohistochemistry Market, by Application, 2022-2031 (USD Million)
• Table 187 China: Immunohistochemistry Market for Research and Other Applications, by Type, 2022-2031 (USD Million)
• Table 188 China: Immunohistochemistry Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 189 China: Immunohistochemistry Market, by End User, 2022-2031 (USD Million)
• Table 190 India: Immunohistochemistry Market, by Offering, 2022-2031 (USD Million)
• Table 191 India: Immunohistochemistry Consumables Market, by Type, 2022-2031 (USD Million)
• Table 192 India: Immunohistochemistry Reagents Market, by Type, 2022-2031 (USD Million)
• Table 193 India: Immunohistochemistry Equipment Market, by Type, 2022-2031 (USD Million)
• Table 194 India: Immunohistochemistry Market, by Method, 2022-2031 (USD Million)
• Table 195 India: Immunohistochemistry Market, by Process, 2022-2031 (USD Million)
• Table 196 India: Immunohistochemistry Market, by Application, 2022-2031 (USD Million)
• Table 197 India: Immunohistochemistry Market for Research and Other Applications, by Type, 2022-2031 (USD Million)
• Table 198 India: Immunohistochemistry Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 199 India: Immunohistochemistry Market, by End User, 2022-2031 (USD Million)
• Table 200 Australia: Immunohistochemistry Market, by Offering, 2022-2031 (USD Million)
• Table 201 Australia: Immunohistochemistry Consumables Market, by Type, 2022-2031 (USD Million)
• Table 202 Australia: Immunohistochemistry Reagents Market, by Type, 2022-2031 (USD Million)
• Table 203 Australia: Immunohistochemistry Equipment Market, by Type, 2022-2031 (USD Million)
• Table 204 Australia: Immunohistochemistry Market, by Method, 2022-2031 (USD Million)
• Table 205 Australia: Immunohistochemistry Market, by Process, 2022-2031 (USD Million)
• Table 206 Australia: Immunohistochemistry Market, by Application, 2022-2031 (USD Million)
• Table 207 Australia: Immunohistochemistry Market for Research and Other Applications, by Type, 2022-2031 (USD Million)
• Table 208 Australia: Immunohistochemistry Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 209 Australia: Immunohistochemistry Market, by End User, 2022-2031 (USD Million)
• Table 210 South Korea: Immunohistochemistry Market, by Offering, 2022-2031 (USD Million)
• Table 211 South Korea: Immunohistochemistry Consumables Market, by Type, 2022-2031 (USD Million)
• Table 212 South Korea: Immunohistochemistry Reagents Market, by Type, 2022-2031 (USD Million)
• Table 213 South Korea: Immunohistochemistry Equipment Market, by Type, 2022-2031 (USD Million)
• Table 214 South Korea: Immunohistochemistry Market, by Method, 2022-2031 (USD Million)
• Table 215 South Korea: Immunohistochemistry Market, by Process, 2022-2031 (USD Million)
• Table 216 South Korea: Immunohistochemistry Market, by Application, 2022-2031 (USD Million)
• Table 217 South Korea: Immunohistochemistry Market for Research and Other Applications, by Type, 2022-2031 (USD Million)
• Table 218 South Korea: Global Immunohistochemistry Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 219 South Korea: Global Immunohistochemistry Market, by End User, 2022-2031 (USD Million)
• Table 220 Rest of Asia-Pacific: Immunohistochemistry Market, by Offering, 2022-2031 (USD Million)
• Table 221 Rest of Asia-Pacific: Immunohistochemistry Consumables Market, by Type, 2022-2031 (USD Million)
• Table 222 Rest of Asia-Pacific: Immunohistochemistry Reagents Market, by Type, 2022-2031 (USD Million)
• Table 223 Rest of Asia-Pacific: Immunohistochemistry Equipment Market, by Type, 2022-2031 (USD Million)
• Table 224 Rest of Asia-Pacific: Immunohistochemistry Market, by Method, 2022-2031 (USD Million)
• Table 225 Rest of Asia-Pacific: Immunohistochemistry Market, by Process, 2022-2031 (USD Million)
• Table 226 Rest of Asia-Pacific: Immunohistochemistry Market, by Application, 2022-2031 (USD Million)
• Table 227 Rest of Asia-Pacific: Immunohistochemistry Market for Research and Other Applications, by Type, 2022-2031 (USD Million)
• Table 228 Rest of Asia-Pacific: Immunohistochemistry Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 229 Rest of Asia-Pacific: Immunohistochemistry Market, by End User, 2022-2031 (USD Million)
• Table 230 Latin America: Immunohistochemistry Market, by Country/Region, 2022-2031 (USD Million)
• Table 231 Latin America: Immunohistochemistry Market, by Offering, 2022-2031 (USD Million)
• Table 232 Latin America: Immunohistochemistry Consumables Market, by Type, 2022-2031 (USD Million)
• Table 233 Latin America: Immunohistochemistry Reagents Market, by Type, 2022-2031 (USD Million)
• Table 234 Latin America: Immunohistochemistry Equipment Market, by Type, 2022-2031 (USD Million)
• Table 235 Latin America: Immunohistochemistry Market, by Method, 2022-2031 (USD Million)
• Table 236 Latin America: Immunohistochemistry Market, by Process, 2022-2031 (USD Million)
• Table 237 Latin America: Immunohistochemistry Market, by Application, 2022-2031 (USD Million)
• Table 238 Latin America: Immunohistochemistry Market for Research and Other Applications, by Type, 2022-2031 (USD Million)
• Table 239 Latin America: Immunohistochemistry Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 240 Latin America: Immunohistochemistry Market, by End User, 2022-2031 (USD Million)
• Table 241 Brazil: Immunohistochemistry Market, by Offering, 2022-2031 (USD Million)
• Table 242 Brazil: Immunohistochemistry Consumables Market, by Type, 2022-2031 (USD Million)
• Table 243 Brazil: Immunohistochemistry Reagents Market, by Type, 2022-2031 (USD Million)
• Table 244 Brazil: Immunohistochemistry Equipment Market, by Type, 2022-2031 (USD Million)
• Table 245 Brazil: Immunohistochemistry Market, by Method, 2022-2031 (USD Million)
• Table 246 Brazil: Immunohistochemistry Market, by Process, 2022-2031 (USD Million)
• Table 247 Brazil: Immunohistochemistry Market, by Application, 2022-2031 (USD Million)
• Table 248 Brazil: Immunohistochemistry Market for Research and Other Applications, by Type, 2022-2031 (USD Million)
• Table 249 Brazil: Immunohistochemistry Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 250 Brazil: Immunohistochemistry Market, by End User, 2022-2031 (USD Million)
• Table 251 Mexico: Immunohistochemistry Market, by Offering, 2022-2031 (USD Million)
• Table 252 Mexico: Immunohistochemistry Consumables Market, by Type, 2022-2031 (USD Million)
• Table 253 Mexico: Immunohistochemistry Reagents Market, by Type, 2022-2031 (USD Million)
• Table 254 Mexico: Immunohistochemistry Equipment Market, by Type, 2022-2031 (USD Million)
• Table 255 Mexico: Immunohistochemistry Market, by Method, 2022-2031 (USD Million)
• Table 256 Mexico: Immunohistochemistry Market, by Process, 2022-2031 (USD Million)
• Table 257 Mexico: Immunohistochemistry Market, by Application, 2022-2031 (USD Million)
• Table 258 Mexico: Immunohistochemistry Market for Research and Other Applications, by Type, 2022-2031 (USD Million)
• Table 259 Mexico: Immunohistochemistry Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 260 Mexico: Immunohistochemistry Market, by End User, 2022-2031 (USD Million)
• Table 261 Rest of Latin America: Immunohistochemistry Market, by Offering, 2022-2031 (USD Million)
• Table 262 Rest of Latin America: Immunohistochemistry Consumables Market, by Type, 2022-2031 (USD Million)
• Table 263 Rest of Latin America: Immunohistochemistry Reagents Market, by Type, 2022-2031 (USD Million)
• Table 264 Rest of Latin America: Immunohistochemistry Equipment Market, by Type, 2022-2031 (USD Million)
• Table 265 Rest of Latin America: Immunohistochemistry Market, by Method, 2022-2031 (USD Million)
• Table 266 Rest of Latin America: Immunohistochemistry Market, by Process, 2022-2031 (USD Million)
• Table 267 Rest of Latin America: Immunohistochemistry Market, by Application, 2022-2031 (USD Million)
• Table 268 Rest of Latin America: Immunohistochemistry Market for Research and Other Applications, by Type, 2022-2031 (USD Million)
• Table 269 Rest of Latin America: Immunohistochemistry Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 270 Rest of Latin America: Immunohistochemistry Market, by End User, 2022-2031 (USD Million)
• Table 271 Middle East & Africa: Immunohistochemistry Market, by Offering, 2022-2031 (USD Million)
• Table 272 Middle East & Africa: Immunohistochemistry Consumables Market, by Type, 2022-2031 (USD Million)
• Table 273 Middle East & Africa: Immunohistochemistry Reagents Market, by Type, 2022-2031 (USD Million)
• Table 274 Middle East & Africa: Immunohistochemistry Equipment Market, by Type, 2022-2031 (USD Million)
• Table 275 Middle East & Africa: Immunohistochemistry Market, by Method, 2022-2031 (USD Million)
• Table 276 Middle East & Africa: Immunohistochemistry Market, by Process, 2022-2031 (USD Million)
• Table 277 Middle East & Africa: Immunohistochemistry Market, by Application, 2022-2031 (USD Million)
• Table 278 Middle East & Africa: Immunohistochemistry Market for Research and Other Applications, by Type, 2022-2031 (USD Million)
• Table 279 Middle East & Africa: Immunohistochemistry Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 280 Middle East & Africa: Immunohistochemistry Market, by End User, 2022-2031 (USD Million)
• Table 281 Recent Developments, by Company, 2021-2024

LIST OF FIGURES

• Figure 1 Research Process
• Figure 2 Key Secondary Sources
• Figure 3 Primary Research Techniques
• Figure 4 Key Executives Interviewed
• Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
• Figure 6 Market Size Estimation
• Figure 7 Global Immunohistochemistry Market, by Offering, 2024 VS. 2031 (USD Million)
• Figure 8 Global Immunohistochemistry Market, by Method, 2024 VS. 2031 (USD Million)
• Figure 9 Global Immunohistochemistry Market, by Process, 2024 VS. 2031 (USD Million)
• Figure 10 Global Immunohistochemistry Market, by Application, 2024 VS. 2031 (USD Million)
• Figure 11 Global Immunohistochemistry Market, by End User, 2024 VS. 2031 (USD Million)
• Figure 12 Global Immunohistochemistry Market, by Geography
• Figure 13 Impact Analysis: Immunohistochemistry Market
• Figure 14 Global Immunohistochemistry Market, by Offering, 2024 VS. 2031 (USD Million)
• Figure 15 Global Immunohistochemistry Market, by Method, 2024 VS. 2031 (USD Million)
• Figure 16 Global Immunohistochemistry Market, by Process, 2024 VS. 2031 (USD Million)
• Figure 17 Global Immunohistochemistry Market, by Application, 2024 VS. 2031 (USD Million)
• Figure 18 Global Immunohistochemistry Market, by End User, 2024 VS. 2031 (USD Million)
• Figure 19 Global Immunohistochemistry Market, by Geography, 2024 VS. 2031 (USD Million)
• Figure 20 North America: Immunohistochemistry Market Snapshot
• Figure 21 Europe: Immunohistochemistry Market Snapshot
• Figure 22 Asia-Pacific: Immunohistochemistry Market Snapshot
• Figure 23 Latin America: Immunohistochemistry Market Snapshot
• Figure 24 Key Growth Strategies Adopted by Leading Players, 2020-2024
• Figure 25 Global Immunohistochemistry Market: Competitive Benchmarking, by Offering
• Figure 26 Global Immunohistochemistry Market: Competitive Benchmarking, by Method
• Figure 27 Global Immunohistochemistry Market: Competitive Benchmarking, by Geography
• Figure 28 Global Immunohistochemistry Market: Competitive Dashboard
• Figure 29 Global Immunohistochemistry Market: Market Share Analysis/Market Ranking, By Key Players, 2024
• Figure 30 F. Hoffmann-La Roche Ltd: Financial Overview (2024)
• Figure 31 Danaher Corporation: Financial Overview (2024)
• Figure 32 Agilent Technologies, Inc.: Financial Overview (2024)
• Figure 33 Merck KGaA: Financial Overview (2024)
• Figure 34 Bio-Rad Laboratories, Inc.: Financial Overview (2024)
• Figure 35 Thermo Fisher Scientific Inc.: Financial Overview (2024)
• Figure 38 PerkinElmer, Inc.: Financial Overview (2024)

Immunohistochemistry (IHC) Market Size, Share, Forecast, & Trends Analysis by Offering (Reagents [Fixation, Buffer, Blocking, Antibodies], Kits, Equipment [Staining, Imaging] Method (ABC, CSA, PAP) Process, Application, End User-Global Forecast to 2031

The global immunohistochemistry market is projected to reach $4.08 billion by 2031 at a CAGR of 7.2% from 2024 to 2031.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the global immunohistochemistry market is driven by the increasing prevalence of chronic diseases, among geriatric populations, increasing emphasis on rare diseases, growing awareness toward the importance of early disease diagnosis, rising R&D expenditure, growing demand for drug discovery and development, increasing burden of infectious diseases, increasing funding for research activities and rising healthcare expenditure. However, the lack of standardized protocols is restraining the growth of this market.

Furthermore, inclination toward personalized medicine, innovations in genomics and proteomics, and increasing automation in histochemistry are expected to generate market growth opportunities. However, the availability of alternative technologies is a major challenge in the global immunohistochemistry market.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry in the past three to four years. The key players operating in the immunohistochemistry market are F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (U.S.), Agilent Technologies, Inc. (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), Eagle Biosciences, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S), Cell Signaling Technology, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Bio SB Inc. (U.S.), Biocare Medical, LLC. (U.S.), Bio-Genex Laboratories (U.S.), and CANDOR Bioscience GmbH (Germany).

Among all the offerings studied in this report, in 2024, the consumables segment is expected to account for the largest share of 68.4% of the immunohistochemistry market. The large market share of this segment is attributed to the advancements in kits and reagents enabling laboratories to perform multiple tests simultaneously, the rising burden of chronic diseases, and growing research in genetic and rare diseases by biopharmaceutical companies, contract research organizations, and research laboratories.

Among all the methods studied in this report, in 2024, the avidin-biotin complex is expected to account for the largest share of 30.8% of the immunohistochemistry market. The large market share of this segment is attributed to the various advantages of avidin-biotin complexes, such as resistivity to enzymatic reactions, change in pH, temperature, denaturation, and organic reagents, increased detection efficiency, low primary antibody consumption, and less assay time as compared to other methods.

Among all the applications studied in this report, in 2024, the clinical applications segment is expected to account for the largest share of the immunohistochemistry market. The segment's large market share can be attributed to the rising burden of cancer, the rising awareness of the advantages of immunohistochemistry testing for treatment purposes among healthcare professionals, and the increasing number of diagnostic laboratories. For instance, according to the American Cancer Society, around 20 million new cancer cases were newly diagnosed, and 9.7 million individuals died from the cancer worldwide in 2022. The number of cases is expected to reach up to 35 million by 2050. This increases the demand for immunohistochemistry tests for disease detection.

Among all the end users studied in this report, in 2024, the hospitals and diagnostic laboratories segment is expected to account for the largest share of the immunohistochemistry market. This segment's largest share is attributed to the increasing incidences of cancer, high healthcare expenditures, and the increasing number of hospitals in both developed and developing countries. Furthermore, patients' inclination toward hospitals due to well-established infrastructure, availability of skilled professionals, medical facilities, and advanced treatments also support the large market share of hospitals and diagnostic laboratories.

An in-depth analysis of the geographical scenario of the global immunohistochemistry market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. Asia-Pacific is projected to register the highest CAGR of 13.0% during the forecast period. Accelerated growth in emerging countries in Asia-Pacific has relatively increased the emphasis of various governments towards the healthcare sector in terms of increased investments to enhance the accessibility to healthcare facilities and build better healthcare infrastructure.

Scope of the Report:

Immunohistochemistry Market Assessment-by Offering

• Consumables
  • Reagents
• Fixation Reagents
• Antigen Retrieval
• Buffers
• Blocking Reagents
• Antibodies
• Control Reagents
• Chromogenic Substrates
• Counterstain
  • Other accessories
• Equipment
  • Staining Systems
  • Imaging Systems
  • Slide Scanners
  • Tissue Microarrays
• Services & Software

Note: other accessories include glass slides, racks & vials, mounting media, and organic solvents.

Immunohistochemistry Market Assessment-by Method

• Avidin-Biotin Complex
• Polymer-Based Immunohistochemistry
• Catalyzed Signal Amplification (CSA)
• Fluorescyl-tyramide Amplification
• Improved Catalyzed Signal Amplification (iCSA)
• Multi-Staining Immunohistochemistry
• Labeled Streptavidin Biotin (LSAB)
• PAP Method

Immunohistochemistry Market Assessment-by Process

• Sample Preparation
• Antigen Retrieval
• Background Blocking
• Target Detection
• Sample Visualization

Immunohistochemistry Market Assessment-by Application

• Research and Other Applications
  • Drug Discovery
  • Agriculture & Animal Research
  • Other Applications
• Clinical Applications
  • Reproductive Health
  • Oncology
  • Infectious Disease
  • Other Clinical Applications

Note 1: Other applications include food microbiology, microbiota analysis in the beverage industry, and environmental studies.

Note 2: Other clinical applications include the detection of genetic aberrations in neurological disorders, rare diseases, metabolic and immune disorders, and food-borne illnesses.

Immunohistochemistry Market Assessment-by End User

• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Laboratories
• Academic Institutes & Research Centers
• Other End Users

Note: Other end users include forensic laboratories and transfusion laboratories.

Immunohistochemistry Market Assessment-by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K
  • Italy
  • Spain
  • Rest of Europe (RoE)
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific (RoAPAC)
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition & Scope
• 1.2. Market Ecosystem
• 1.3. Currency & Limitations
• 1.4. Key Stakeholders

2. Research Methodology

• 2.1. Research Approach
• 2.2. Process of Data Collection & Validation
  • 2.2.1. Secondary Research
  • 2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
• 2.3. Market Sizing and Forecasting
  • 2.3.1. Market Size Estimation Approach
  • 2.3.2. Growth Forecast Approach
  • 2.3.3. Market Share Analysis
• 2.4. Assumptions for the Study

3. Executive Summary

4. Factors Affecting Market Growth

• 4.1. Overview
• 4.2. Drivers
  • 4.2.1. Rising Prevalence of Chronic Diseases Coupled with the Increasing Geriatric Population
  • 4.2.2. Increasing Focus on Rare Disease
  • 4.2.3. Rising Awareness Regarding Early Disease Diagnosis
  • 4.2.4. Increasing Research and Development Expenditure
  • 4.2.5. Rising Demand for Drug Discovery and Development
  • 4.2.6. Rising Prevalence of Infectious Diseases
  • 4.2.7. Increasing Funding for Research Activities
  • 4.2.8. Rising Healthcare Expenditure
• 4.3. Restraints
  • 4.3.1. Lack of Standardized Protocols
• 4.4. Opportunities
  • 4.4.1. Increasing Inclination Toward Personalized Medicine
  • 4.4.2. Advancements in Genomics and Proteomics
  • 4.4.3. Increasing Automation in Immunohistochemistry
• 4.5. Challenges
  • 4.5.1. Availability of Alternative Technology
• 4.6. Trends
  • 4.6.1. AI-Based Histochemistry
  • 4.6.2. Use of Multiplex IHC
• 4.7. Factor Analysis
• 4.8. Case Studies
• 4.9. Pricing Analysis
• 4.10. Regulatory Analysis
  • 4.10.1. U.S.
  • 4.10.2. Canada
  • 4.10.3. Europe
  • 4.10.4. China
  • 4.10.5. Japan
  • 4.10.6. India
  • 4.10.7. Latin America
  • 4.10.8. Middle East
• 4.11. Pricing Analysis
• 4.12. Porter's Five Forces Analysis

5. Immunohistochemistry Market Assessment-by Offering

• 5.1. Overview
• 5.2. Consumables
  • 5.2.1. Reagents
    • 5.2.1.1. Fixation Reagents
    • 5.2.1.2. Antigen Retrieval
    • 5.2.1.3. Buffers
    • 5.2.1.4. Blocking Reagents
    • 5.2.1.5. Antibodies
    • 5.2.1.6. Control Reagents
    • 5.2.1.7. Chromogenic Substrates
    • 5.2.1.8. Counterstain
  • 5.2.2. Other Accessories
• 5.3. Equipment
  • 5.3.1. Staining System
  • 5.3.2. Imaging Systems
  • 5.3.3. Slide Scanners
  • 5.3.4. Tissue Microarrays
• 5.4. Services & Software

6. Immunohistochemistry Market Assessment-by Method

• 6.1. Overview
• 6.2. Avidin-Biotin Complex
• 6.3. Polymer-Based Immunohistochemistry
• 6.4. Catalyzed Signal Amplification (CSA)
• 6.5. Fluorescyl-tyramide Amplification
• 6.6. Improved Catalyzed Signal Amplification (iCSA)
• 6.7. Multi-Staining Immunohistochemistry
• 6.8. Labeled Streptavidin Biotin (LSAB)
• 6.9. PAP Method

7. Immunohistochemistry Market Assessment-by Process

• 7.1. Overview
• 7.2. Sample Preparation
• 7.3. Antigen Retrieval
• 7.4. Background Blocking
• 7.5. Target Detection
• 7.6. Sample Visualization

8. Immunohistochemistry Market Assessment-by Application

• 8.1. Overview
• 8.2. Research and Other Applications
  • 8.2.1. Drug Discovery
  • 8.2.2. Agriculture & Animal Research
  • 8.2.3. Other Applications
• 8.3. Clinical Applications
  • 8.3.1. Reproductive Health
  • 8.3.2. Oncology
  • 8.3.3. Infectious Disease
  • 8.3.4. Other Clinical Applications

9. Immunohistochemistry Market Assessment-by End User

• 9.1. Overview
• 9.2. Pharmaceutical & Biotechnology Companies
• 9.3. Hospitals & Diagnostic Laboratories
• 9.4. Academic Institutes & Research Centers
• 9.5. Contract Research Organizations
• 9.6. Other End Users

10. Immunohistochemistry Market Assessment-by Geography

• 10.1. Overview
• 10.2. North America
  • 10.2.1. U.S.
  • 10.2.2. Canada
• 10.3. Europe
  • 10.3.1. Germany
  • 10.3.2. France
  • 10.3.3. U.K.
  • 10.3.4. Italy
  • 10.3.5. Spain
  • 10.3.6. Rest of Europe
• 10.4. Asia-Pacific
  • 10.4.1. Japan
  • 10.4.2. China
  • 10.4.3. India
  • 10.4.4. Australia
  • 10.4.5. South Korea
  • 10.4.6. Rest of Asia-Pacific
• 10.5. Latin America
  • 10.5.1. Brazil
  • 10.5.2. Mexico
  • 10.5.3. Rest of Latin America
• 10.6. Middle East & Africa

11. Competition Analysis

• 11.1. Overview
• 11.2. Key Growth Strategies
• 11.3. Competitive Benchmarking
• 11.4. Competitive Dashboard
  • 11.4.1. Industry Leaders
  • 11.4.2. Market Differentiators
  • 11.4.3. Vanguards
  • 11.4.4. Emerging Companies
• 11.5. Market Share Analysis/Market Rankings of Key Players (2023)

12. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis*)

• 12.1. F. Hoffmann-La Roche Ltd (Switzerland)
• 12.2. Danaher Corporation (U.S.)
• 12.3. Agilent Technologies, Inc. (U.S.)
• 12.4. Merck KGaA (Germany)
• 12.5. Bio-Rad Laboratories, Inc. (U.S.)
• 12.6. Eagle Biosciences, Inc. (U.S.)
• 12.7. Thermo Fisher Scientific Inc. (U.S)
• 12.8. Cell Signaling Technology, Inc. (U.S.)
• 12.9. PerkinElmer, Inc. (U.S.)
• 12.10. Bio SB Inc. (U.S.)
• 12.11. Biocare Medical, LLC. (U.S.)
• 12.12. Bio-Genex Laboratories (U.S.)
• 12.13. CANDOR Bioscience GmbH (Germany)
• 12.14. Innovex Biosciences Inc. (U.S.)

(Note: SWOT analysis of the top 5 companies will be provided.)

13. Appendix

• 13.1. Available Customization
• 13.2. Related Reports